-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Initiates Coverage On Edwards Lifesciences with Overweight Rating, Announces Price Target of $110

Benzinga·10/07/2026 12:40:08
語音播報
Barclays analyst Christopher Pasquale initiates coverage on Edwards Lifesciences (NYSE:EW) with a Overweight rating and announces Price Target of $110.